SearchDictionaryMobileLogin

Prolonged efficacy of infliximab for refractory adult-onset Still's disease.

AuthorsM S Dilhuydy, R Vatan, G Etienne, M Longy-Boursier, P Mercié
JournalClinical and experimental rheumatology (Clin Exp Rheumatol) 2005 Jan-Feb Vol. 23 Issue 1 Pg. 121-2 ISSN: 0392-856X Italy
PMID15789901 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • infliximab
Topics
  • Adult
  • Antibodies, Monoclonal (therapeutic use)
  • Antirheumatic Agents (therapeutic use)
  • Female
  • Humans
  • Still's Disease, Adult-Onset (drug therapy)
  • Time Factors
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)